Weight-loss drug maker Kailera Therapeutics debuted on Nasdaq on Friday, opening at $26 per share—up 62.5% from its IPO price of $16. Intraday gains held around 57%, with its market value surpassing $2 billion.

Weight-loss drug maker Kailera Therapeutics debuted on Nasdaq on Friday, opening at $26 per share—up 62.5% from its IPO price of $16. Intraday gains held around 57%, with its market value surpassing $2 billion.

老虎证券2026/04/17 19:18

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This IPO raised $625 million, making it the largest IPO in the U.S. biotechnology sector since 2021.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Weight-loss drug maker Kailera Therapeutics debuted on Nasdaq on Friday, opening at $26 per share—up 62.5% from its IPO price of $16. Intraday gains held around 57%, with its market value surpassing $2 billion.

You may also like

Crypto prices